Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)
Condition(s):Malignant Lymphoma of Extranodal and/or Solid Organ Site; Solid TumorLast Updated:July 23, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Malignant Lymphoma of Extranodal and/or Solid Organ Site; Solid TumorLast Updated:July 23, 2019Unknown status
Condition(s):Advanced Solid Tumors; LymphomasLast Updated:June 18, 2015Completed
Condition(s):Corpus Uteri; Lung CancerLast Updated:January 7, 2010Completed
Condition(s):Extensive Stage Small Cell Lung Cancer; Recurrent Small Cell Lung CancerLast Updated:June 26, 2020Terminated
Condition(s):Lung Diseases; CancerLast Updated:May 19, 2010Completed
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:May 30, 2013Completed
Condition(s):Ewing’s SarcomaLast Updated:August 2, 2012Completed
Condition(s):Lung Diseases; CancerLast Updated:May 12, 2016Withdrawn
Condition(s):Urothelial Carcinoma; Urothelial Cancer; Lung Neoplasms; Small Cell Lung Cancer; Prostate CancerLast Updated:February 26, 2024Recruiting
Condition(s):Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction; Diffuse Adenocarcinoma of the Stomach; Intestinal Adenocarcinoma of the Stomach; Mixed Adenocarcinoma of the Stomach; Recurrent Esophageal Cancer; Recurrent Gastric Cancer; Squamous Cell Carcinoma of the Esophagus; Stage IIIB Esophageal Cancer; Stage IIIB Gastric Cancer; Stage IIIC Esophageal Cancer; Stage IIIC Gastric Cancer; Stage IV Esophageal Cancer; Stage IV Gastric CancerLast Updated:February 1, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.